Fluorine walk: The impact of fluorine in quinolone amides on their activity against African sleeping sickness

被引：9

作者：

Berninger, Michael ^{[1
]}

Erk, Christine ^{[1
]}

Fuss, Antje ^{[2
]}

Skaf, Joseph ^{[1
]}

Al-Momani, Ehab ^{[3
]}

Israel, Ina ^{[3
]}

Raschig, Martina ^{[1
]}

Guentzel, Paul ^{[1
]}

Samnick, Samuel ^{[3
]}

Holzgrabe, Ulrike ^{[1
]}

机构：

[1] Univ Wurzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany

[2] Med Mission Inst Wurzburg, Hermann Schell Str 7, D-97074 Wurzburg, Germany

[3] Univ Hosp Wurzburg, Dept Nucl Med, Oberduerrbacher Str 6, D-97080 Wurzburg, Germany

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2018年 / 152卷

关键词：

Quinolone amides; Trypanosoma brucei brucei; Structure-activity relationship; Fluorine walk; Metabolism; Blood-brain barrier; Autoradiography; TRYPANOSOMA-BRUCEI; MEDICINAL CHEMISTRY; DISCOVERY; DERIVATIVES; RHODESIENSE; CHALLENGES; GAMBIENSE; AGENT; ACIDS; ASSAY;

D O I：

10.1016/j.ejmech.2018.04.055

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Human African Trypanosomiasis, also known as African sleeping sickness, is caused by the parasitic protozoa of the genus Trypanosoma. If there is no pharmacological intervention, the parasites can cross the blood-brain barrier (BBB), inevitably leading to death of the patients. Previous investigation identified the quinolone amide GHQ168 as a promising lead compound having a nanomolar activity against T b. brucei. Here, the role of a fluorine substitution at different positions was investigated in regard to toxicity, pharmacokinetics, and antitrypanosomal activity. This 'fluorine walk' led to new compounds with improved metabolic stability and consistent activity against T. b. brucei. The ability of the new quinolone amides to cross the BBB was confirmed using an F-18-labelled quinolone amide derivative by means of ex vivo autoradiography of a murine brain. (C) 2018 Elsevier Masson SAS. All rights reserved.

引用

页码：377 / 391

页数：15

共 38 条

[1] A NEW RAPID AND SIMPLE NONRADIOACTIVE ASSAY TO MONITOR AND DETERMINE THE PROLIFERATION OF LYMPHOCYTES - AN ALTERNATIVE TO [H-3] THYMIDINE INCORPORATION ASSAY [J].

AHMED, SA ;

GOGAL, RM ;

WALSH, JE .

JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 170 (02) :211-224

[2] Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with β-amyloid, acetylcholine, and butyrylcholine esterases [J].

Alptuzun, Vildan ;

Prinz, Michaela ;

Hoerr, Verena ;

Scheiber, Josef ;

Radacki, Krzysztof ;

Fallarero, Adyary ;

Vuorela, Pia ;

Engels, Bernd ;

Braunschweig, Holger ;

Erciyas, Ercin ;

Holzgrabe, Ulrike .

BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (05) :2049-2059

[3] F-18-labeling and biodistribution of the novel fluoro-quinolone antimicrobial agent, trovafloxacin (CP 99,219) [J].

Babich, JW ;

Rubin, RH ;

Graham, WA ;

Wilkinson, RA ;

Vincent, J ;

Fischman, AJ .

NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (08) :995-998

[4] CULTIVATION IN A SEMI-DEFINED MEDIUM OF ANIMAL INFECTIVE FORMS OF TRYPANOSOMA-BRUCEI, TRYPANOSOMA-EQUIPERDUM, TRYPANOSOMA-EVANSI, TRYPANOSOMA-RHODESIENSE AND T-GAMBIENSE [J].

BALTZ, T ;

BALTZ, D ;

GIROUD, C ;

CROCKETT, J .

EMBO JOURNAL, 1985, 4 (05) :1273-1277

[5] Fluorine in medicinal chemistry [J].

Böhm, HJ ;

Banner, D ;

Bendels, S ;

Kansy, M ;

Kuhn, B ;

Müller, K ;

Obst-Sander, U ;

Stahl, M .

CHEMBIOCHEM, 2004, 5 (05) :637-643

[6] Human African trypanosomiasis [J].

Brun, Reto ;

Blum, Johannes ;

Chappuis, Francois ;

Burri, Christian .

LANCET, 2010, 375 (9709) :148-159

[7] The discovery of ezetimibe: A view from outside the receptor [J].

Clader, JW .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (01) :1-9

[8] Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei [J].

Cleghorn, Laura A. T. ;

Albrecht, Sebastien ;

Stojanovski, Laste ;

Simeons, Frederick R. J. ;

Norval, Suzanne ;

Kime, Robert ;

Collie, Iain T. ;

De Rycker, Manu ;

Campbell, Lorna ;

Hallyburton, Irene ;

Frearson, Julie A. ;

Wyatt, Paul G. ;

Read, Kevin D. ;

Gilbert, Ian H. .

JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (19) :7695-7706

[9] Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders [J].

Conn, P. Jeffrey ;

Lindsley, Craig W. ;

Meiler, Jens ;

Niswender, Colleen M. .

NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (09) :692-708

[10] HETEROCYCLIC BASIC COMPOUNDS .7. 7-BROMO-QUINOLINES AND 7-IODO-QUINOLINES [J].

CONROY, AE ;

MOSHER, HS ;

WHITMORE, FC .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1949, 71 (09) :3236-3237

← 1 2 3 4 →